We're delighted to add our latest Educational Series titled: Apalutamide in men with metastatic hormone-sensitive prostate cancer.
This review summarises prostate cancer and the current available treatments, specific treatment of metastatic hormone-sensitive prostate cancer and a focus on the use of Apalutamide.
The review includes guiding commentary from Associate Professor Niall Corcoran, a urological surgeon at the Royal Melbourne and Frankston Hospitals, and a principal research fellow in the Department of Surgery, University of Melbourne.
Please login below to download this issue (PDF)